文献速递神经肿瘤

TRDMT1甲基转移酶敲除影响胶质母细胞瘤细胞DNA甲基化组

Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells.
PubMed 文献 · J Neurooncol · 2023-05-11

该研究采用CRISPR方法获得TRDMT1敲除的胶质母细胞瘤细胞,发现敲除细胞总5-甲基胞嘧啶、DNMT1水平和DNMT活性降低,RRBS分析显示对照组与敲除组甲基化相关差异甲基化位点连锁基因存在统计学显著差异,结论提出TRDMT1可能作为基因表达的新型调节因子,其水平和突变状态应作为预后标志物并在胶质母细胞瘤进展中仔细监测。

要点

  • TRDMT1敲除胶质母细胞瘤细胞总5-甲基胞嘧啶水平降低。
  • TRDMT1敲除细胞DNMT1水平和DNMT活性降低。
  • RRBS显示对照组与TRDMT1敲除组甲基化相关差异甲基化位点连锁基因有统计学显著差异。

核心结论

  • TRDMT1可能作为通过改变DNA甲基化组调节基因表达的新型调节因子,可能影响化疗期间癌细胞命运。
  • 作者认为TRDMT1的水平和突变状态应作为预后标志物,并在胶质母细胞瘤进展中仔细监测。

研究设计与样本

  • 采用基于CRISPR的方法获得TRDMT1敲除的胶质母细胞瘤细胞。
  • 使用ELISA研究DNA中总5-甲基胞嘧啶水平、DNMT1水平和DNMT活性。
  • 采用简化代表性亚硫酸氢盐测序(RRBS)全面评估TRDMT1敲除胶质母细胞瘤细胞的DNA甲基化组。

主要发现

  • TRDMT1敲除细胞的特征是DNA中总5-甲基胞嘧啶水平降低、DNMT1水平降低和DNMT活性降低。
  • 基于RRBS的甲基化组分析显示,对照组细胞与TRDMT1敲除细胞相比,甲基化相关差异甲基化位点连锁基因存在统计学显著差异。
  • TRDMT1敲除相关DNA甲基化组变化可能影响端粒维持、细胞周期和长寿调节通路、蛋白质稳态、DNA和RNA生物学等多个过程和通路的活性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We have previously shown that TRDMT1 methyltransferase is a regulator of chemotherapy-associated responses in glioblastoma cells. Despite the fact that glioblastoma, a common and malignant brain tumor, is widely characterized in terms of genetic and epigenetic markers, there are no data on TRDMT1-related changes in 5-methylcytosine pools in the genome. In the present study, the effect of TRDMT1 gene knockout (KO) on DNA methylome was analyzed. METHODS: CRISPR-based approach was used to obtain TRDMT1 KO glioblastoma cells. Total 5-methylcytosine levels in DNA, DNMT1 pools and DNMT activity were studied using ELISA. Reduced representation bisulfite sequencing (RRBS) was considered to comprehensively evaluate DNA methylome in glioblastoma cells with TRDMT1 KO. RESULTS: TRDMT1 KO cells were characterized by decreased levels of total 5-methylcytosine in DNA and DNMT1, and DNMT activity. RRBS-based methylome analysis revealed statistically significant differences in methylation-relevant DMS-linked genes in control cells compared to TRDMT1 KO cells. TRDMT1 KO-associated changes in DNA methylome may affect the activity of several processes and pathways such as telomere maintenance, cell cycle and longevity regulating pathway, proteostasis, DNA and RNA biology. CONCLUSIONS: TRDMT1 may be suggested as a novel modulator of gene expression by changes in DNA methylome that may affect cancer cell fates during chemotherapy. We postulate that the levels and mutation status of TRDMT1 should be considered as a prognostic marker and carefully monitored during glioblastoma progression.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zabek T, Szmatola T, Adamczyk-Grochala J, et al. Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells. J Neurooncol. 2023. PMID: 37169948. doi:10.1007/s11060-023-04304-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。